Steinbeißer Project Management
Some news ...
Giving patients a voice in drug development - PREFER is a five year project funded by the Innovative Medicines Initiative (IMI), to evaluate different preference elicitation methods and test them in a clinical setting.
16 pharmaceutical companies and 16 public partners form the project consortium with a total budget of 12 million €.
For more info: www.imi-prefer.eu
We love what we do and we strongly believe that European funded research has an impact. Unfortunately there is still a lot of administrative burden for researchers. During setting up a special project such as a European funded collaboration many do reinvent the wheel again. We want to be part of a global solution minimizing the burden not only for our clients. Therefore we will share our best practice templates under a free licence to increase the efficiency of research.